The OR of the Future is HERE

Details

Category: News & Events

Created: Thursday, 24 February 2022 09:37

Robotic technology is helping to shape the future of medicine as we know it. For over 20 years, Anderson’s collaboration with Intuitive – the maker of DaVinci robotics -- has elevated the surgical program at Anderson Hospital. The DaVinci system has expanded surgeons’ capabilities to perform minimally invasive surgery for even the most complicated scenarios. As technology advances, we advance along with it, and excited to bring the newest DaVinci Xi system to our surgeons and patients.

As the field of robotics has gained momentum and evolved as a medical school staple nationwide, obtaining this revolutionary technology also provides Anderson new recruitment opportunities and aids in securing future healthcare experts.

Designed with the latest robotic, computer, and optical innovations, the da Vinci Xi features a high-definition 3D (HD-3D) vision system, Intuitive Motion Technology, specialized ‘wristed’ instruments, and smart software that allow surgeons to operate with unparalleled precision, dexterity, and control. The system utilizes wireless capabilities and functions with ‘video-game-like’ motion controlled by the expertly trained surgeon. With its savvy visualization tools, coupled with a dynamic ‘moving bed’ that maneuvers patients into the ideal operating position, the da Vinci Xi facilitates easy access to even the most hard-to-reach areas inside the body. Additionally, the system and its movements are programmed to be entirely controlled by a surgeon, which translates into smaller, more defined hand movements for optimal results. Consequently, patients benefit from a quicker procedure time, shorter hospital stay, faster recovery, minimal scaring, and less need for narcotic pain medications.

“Acquiring the latest generation of robotic technology aligns directly with our commitment to advancing healthcare and investing in the future of our community,” said Keith Page, Anderson Healthcare President and CEO. “Upon evaluating the newest research surrounding robotics and improved patient outcomes, we felt that now was the best time for us to invest in the da Vinci Xi.”